We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.56%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17%
2 Financials 13.53%
3 Healthcare 13.33%
4 Technology 13.18%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RIGL icon
1451
Rigel Pharmaceuticals
RIGL
$776M
$254K ﹤0.01%
+8,982
New +$320K
2018 Q2
0 quarters
QTNT
1452
DELISTED
Quotient Ltd
QTNT
$254K ﹤0.01%
+791
New +$185K
2018 Q2
0 quarters
HWM icon
1453
Howmet Aerospace
HWM
$86.8B
$253K ﹤0.01%
19,430
-81,266
-81% -$1.21M
2017 Q2
4 quarters
DOVA
1454
DELISTED
Dova Pharmaceuticals
DOVA
$253K ﹤0.01%
+8,464
New +$230K
2018 Q2
0 quarters
ALNA
1455
DELISTED
Allena Pharmaceuticals
ALNA
$252K ﹤0.01%
+19,311
New +$278K
2018 Q2
0 quarters
EPZM
1456
DELISTED
Epizyme
EPZM
$251K ﹤0.01%
18,549
+4,497
+32% +$70K
2018 Q1
1 quarter
RLH
1457
DELISTED
Red Lions Hotel
RLH
$251K ﹤0.01%
+21,564
New +$229K
2018 Q2
0 quarters
KPTI icon
1458
DELISTED
Karyopharm Therapeutics
KPTI
$250K ﹤0.01%
+980
New +$242K
2018 Q2
0 quarters
MMI icon
1459
Marcus & Millichap
MMI
$873M
$250K ﹤0.01%
+6,400
New +$236K
2018 Q2
0 quarters
PFGC icon
1460
Performance Food Group
PFGC
$17B
$250K ﹤0.01%
+6,800
New +$230K
2018 Q2
0 quarters
HURN icon
1461
Huron Consulting
HURN
$2.63B
$249K ﹤0.01%
+6,078
New +$237K
2018 Q2
0 quarters
AQ
1462
DELISTED
Aquantia
AQ
$249K ﹤0.01%
+21,477
New +$278K
2018 Q2
0 quarters
CBZ icon
1463
DELISTED
CBIZ
CBZ
$248K ﹤0.01%
10,800
-515
-5% -$10.4K
2017 Q4
2 quarters
SAFE icon
1464
Safehold
SAFE
$656M
$247K ﹤0.01%
4,703
+1,905
+68% +$98.1K
2017 Q4
2 quarters
TTI icon
1465
TETRA Technologies
TTI
$951M
$246K ﹤0.01%
55,173
-51,593
-48% -$213K
2017 Q3
3 quarters
MCRN
1466
DELISTED
Milacron Holdings
MCRN
$246K ﹤0.01%
+13,000
New +$256K
2018 Q2
0 quarters
ARR icon
1467
Armour Residential REIT
ARR
$1.61B
$245K ﹤0.01%
+2,152
New +$247K
2018 Q2
0 quarters
JNP
1468
DELISTED
Juniper Pharmaceuticals
JNP
$244K ﹤0.01%
+28,100
New +$253K
2018 Q2
0 quarters
ABEV icon
1469
Ambev
ABEV
$41B
$243K ﹤0.01%
52,444
+33,419
+176% +$196K
2018 Q1
1 quarter
PAC icon
1470
Grupo Aeroportuario del Pacifico
PAC
$13.4B
$243K ﹤0.01%
+2,620
New +$248K
2018 Q2
0 quarters
PDCE
1471
DELISTED
PDC Energy
PDCE
$243K ﹤0.01%
4,023
-6,883
-63% -$397K
2017 Q3
3 quarters
EZPW icon
1472
Ezcorp
EZPW
$1.56B
$242K ﹤0.01%
+20,059
New +$263K
2018 Q2
0 quarters
BBSI icon
1473
Barrett Business Services
BBSI
$721M
$241K ﹤0.01%
10,000
-15,132
-60% -$327K
2017 Q4
2 quarters
LNG icon
1474
Cheniere Energy
LNG
$60.3B
$241K ﹤0.01%
+3,700
New +$228K
2018 Q2
0 quarters
UTL icon
1475
Unitil
UTL
$1.02B
$241K ﹤0.01%
+4,721
New +$227K
2018 Q2
0 quarters

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.